Acadia Pharmaceuticals buy StockNews.com
Start price
14.09.24
/
50%
€14.60
Target price
14.09.25
-
Performance (%)
36.96%
End price
15.09.25
€19.99
Summary
This prediction ended on 15.09.25 with a price of €19.99. With a performance of 36.96% the BUY prediction by StockNews_com was a big success. StockNews_com has a follow-up prediction for Acadia Pharmaceuticals where he still thinks Acadia Pharmaceuticals is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Acadia Pharmaceuticals | -1.474% | -1.474% | 34.856% |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% |
Comments by StockNews_com for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for ACAD provided by MarketBeat
In the thread Trading Acadia Pharmaceuticals
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Acadia Pharmaceuticals
Stopped prediction by StockNews_com for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€17.09
03.08.24
03.08.24
-
03.08.25
03.08.25
18.53%
04.08.25
04.08.25
